LOS ANGELES, April 20, 2024 /PRNewswire/ — Yeelight, a pioneer in smart lighting solutions, proudly announces its collaboration with SignalRGB, empowering users to seamlessly control Yeelight products alongside other RGB devices for an immersive lighting experience.

SignalRGB is a popular software application that enables users to synchronize RGB lighting effects across various devices from different brands, offering tailored experiences for gamers with battlestation integration, dynamic wallpapers, audio synchronization, and more.

Thanks to the integration, Yeelight users can control a variety of products on SignalRGB, including the Yeelight Cube, Beam RGBIC Light Bar, Obsid RGBIC Light Strip, Monitor Light Bar, and more! Enjoy synchronizing these devices with your gaming peripherals for a new experience.

Yeelight’s Fun portfolio aims to provide users with "The ultimate RGB playground," offering dazzling RGB lighting effects and a wide range of customizable options. With individually addressable light beads, users can unleash their creativity with features like graffiti, DIY modes, clock mode, sync with screen, music, games and beyond!

With SignalRGB integration, users can unlock new possibilities, such as displaying real-time health stats on the Yeelight Cube while playing Minecraft, enhancing their gaming experience in unique and exciting ways.

To celebrate this collaboration, Yeelight and SignalRGB are launching an exclusive giveaway! Ten lucky winners will receive valuable Yeelight devices along with a one-year-long SignalRGB Pro subscription. Keep an eye on their social media channels for a chance to win!

Yeelight remains dedicated to delivering innovative and versatile smart lighting solutions. The support for SignalRGB integration underscores this commitment, enhancing user experiences and broadening the horizons of smart lighting.

For more information about Yeelight and its products, visit store.yeelight.com 

For more information about SignalRGB, visit signalrgb.com 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer

Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with…

Kalkine Australia's The Funds Report: Ranking Australian Managed Funds and ETFs

SYDNEY, June 3, 2025 /PRNewswire/ — Kalkine Australia recently launched its "The…

Empowering Professionals and Aspiring Creators, Snapdragon X2 Plus Delivers Multi-day Battery Life, Fast Performance and Advanced AI

Highlights: Snapdragon® X2 Plus transforms every click and every moment for modern…